Harry F. Hixson, Jr.

2016

In 2016, Harry F. Hixson, Jr. earned a total compensation of $1M as Director and Former Interim Chief Executive Officer and Principal Financial Officer at Arena Pharmaceuticals, a 116% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$560,045
Option Awards$150,925
Salary$281,700
Other$48,395
Total$1,041,065

Hixson received $560K in non-equity incentive plan, accounting for 54% of the total pay in 2016.

Hixson also received $150.9K in option awards, $281.7K in salary and $48.4K in other compensation.

Rankings

In 2016, Harry F. Hixson, Jr.'s compensation ranked 8,045th out of 14,075 executives tracked by ExecPay. In other words, Hixson earned more than 42.8% of executives.

ClassificationRankingPercentile
All
8,045
out of 14,075
43rd
Division
Manufacturing
3,074
out of 5,489
44th
Major group
Chemicals And Allied Products
1,023
out of 1,895
46th
Industry group
Drugs
793
out of 1,538
48th
Industry
Pharmaceutical Preparations
628
out of 1,176
47th
Source: SEC filing on April 28, 2017.

Hixson's colleagues

We found six more compensation records of executives who worked with Harry F. Hixson, Jr. at Arena Pharmaceuticals in 2016.

2016

Amit Munshi

Arena Pharmaceuticals

Chief Executive Officer

2016

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2016

Steven Spector

Arena Pharmaceuticals

General Counsel

2016

Kevin Lind

Arena Pharmaceuticals

Chief Financial Officer

2016

Craig Audet

Arena Pharmaceuticals

Former Senior Vice President, Operations and Head of Global Regulatory Affairs

2016

Vincent Aurentz

Arena Pharmaceuticals

Executive Vice President and Chief Business Officer

You may also like